-
<![CDATA[BGB-B2033 Gains FDA Fast Track Status in Advanced HCC]]>
19 Dec 2025 19:17 GMT
… (Tevimbra), with or without bevacizumab (Avastin), in advanced or metastatic solid … -positive squamous non–small cell lung cancer.
The study is actively recruiting …
-
Stage 4 bowel cancer patient fights for funding of life-prolonging drug
19 Dec 2025 18:19 GMT
… New Zealand, second only to lung cancer.
Bowel Cancer New Zealand said … Cancer New Zealand said Bevacizumab (Avastin), which is a targeted therapy …
-
Mark Cuban drug firm adds cancer biosimilar
19 Dec 2025 18:16 GMT
… a biosimilar to Roche’s Avastin (bevacizumab), which is approved for … ; non-squamous non-small cell lung cancer; recurrent glioblastoma; metastatic renal cell …
-
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
12 Nov 2025 01:12 GMT
… , breast cancer, eye conditions, and lung cancer will benefit from five medicines … ROS1-positive non-small cell lung cancer.
Bevacizumab (Avastin) – secured ongoing access to … funding for faricimab (Vabysmo) and lung cancer treatments. It will use this …
-
<![CDATA[FDA Grants Fast Track Designation to GPC3x4-1BB Bispecific Antibody in HCC]]>
18 Dec 2025 21:37 GMT
… (Tevimbra), with or without bevacizumab (Avastin), in patients with advanced or … -positive squamous non–small cell lung cancer. Patients also had at least …
-
<![CDATA[ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors]]>
13 Oct 2025 22:18 GMT
… trials exploring HER2 alterations in lung tumors, here are some of the … advanced squamous non–small cell lung cancer (NSCLC).
Previously, developers announced prespecified … “overcome the limitations of bevacizumab [Avastin] in treating squamous [NSCLC]” while …
-
Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty
07 Aug 2025 01:09 GMT
… a stage 4 diagnosis of lung cancer.
After her diagnosis, she spent … (Keytruda [pembrolizumab]), two rounds of Avastin (bevacizumab), and one additional round …
-
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
16 Dec 2025 18:59 GMT
… disease who received pelareorep, Avastin, and FOLFIRI. This … 2025 World Conference on Lung Cancer, demonstrating clinically meaningful outcomes … mutant non-small cell lung cancer, advancing two global … mutant non-small cell lung cancer,” said Bing Yao, …
-
Non-Small Cell Lung Cancer Market: Valued at $18.8 Billion in 2024, Expected to Grow at 6.9% CAGR Through 2035
15 Jul 2025 07:59 GMT
… nwgd), a biosimilar to Avastin, for intravenous use. …
Non-Small Cell Lung Cancer Market Segmentation Analysis
Global … Non-Small Cell Lung Cancer Market by Type
• … Others
Global Non-Small Cell Lung Cancer Market by Therapy
• Chemotherapy …
-
Chugai Pharma files for additional indication of Avastin to treat neurofibromatosis type 2
25 Sep 2025 11:16 GMT
… anti-VEGF monoclonal antibody Avastin for Intravenous Infusion 100mg… efficacy and safety of Avastin for NF2.
BeatNF2 study … weeks, both groups received Avastin. The primary endpoint was … recurrent non-small cell lung cancer excluding squamous cell carcinoma, …
About
© 1995-2025